CSF2 and psoriasis: In the context of established treatment strategies for psoriatic skin disease, GM-CSF blockade might possess great potential, especially in the large subgroup of psoriasis patients with musculoskeletal involvement, due to its proven therapeutic benefit in inflammatory arthritis.